WO2014207407A1 - Dispositif de génération d'un champ électromagnétique corrélé au champ électromagnétique du coeur d'un organisme et procédé associé - Google Patents
Dispositif de génération d'un champ électromagnétique corrélé au champ électromagnétique du coeur d'un organisme et procédé associé Download PDFInfo
- Publication number
- WO2014207407A1 WO2014207407A1 PCT/FR2014/051648 FR2014051648W WO2014207407A1 WO 2014207407 A1 WO2014207407 A1 WO 2014207407A1 FR 2014051648 W FR2014051648 W FR 2014051648W WO 2014207407 A1 WO2014207407 A1 WO 2014207407A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electromagnetic field
- heart
- electromagnetic
- signal
- generating
- Prior art date
Links
- 230000005672 electromagnetic field Effects 0.000 title claims abstract description 67
- 230000002596 correlated effect Effects 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims description 22
- 230000000694 effects Effects 0.000 claims abstract description 31
- 238000012545 processing Methods 0.000 claims abstract description 20
- 241001465754 Metazoa Species 0.000 claims abstract description 15
- 230000003287 optical effect Effects 0.000 claims description 22
- 230000000747 cardiac effect Effects 0.000 claims description 17
- 230000005540 biological transmission Effects 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 9
- 230000004936 stimulating effect Effects 0.000 claims description 9
- 230000004217 heart function Effects 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000012800 visualization Methods 0.000 claims description 4
- 238000004590 computer program Methods 0.000 claims description 3
- 238000000718 qrs complex Methods 0.000 claims description 3
- 230000006854 communication Effects 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 238000013523 data management Methods 0.000 claims description 2
- 230000004044 response Effects 0.000 claims description 2
- 230000000638 stimulation Effects 0.000 description 42
- 206010028980 Neoplasm Diseases 0.000 description 14
- 238000011282 treatment Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 8
- 238000001126 phototherapy Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 238000001467 acupuncture Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000010287 polarization Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 230000001360 synchronised effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000010247 heart contraction Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000001020 rhythmical effect Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002554 cardiac rehabilitation Methods 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002064 heart cell Anatomy 0.000 description 2
- 208000024348 heart neoplasm Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 206010014405 Electrocution Diseases 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000037020 contractile activity Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000009091 myxoma Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007604 neuronal communication Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/33—Heart-related electrical modalities, e.g. electrocardiography [ECG] specially adapted for cooperation with other devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
Definitions
- the present invention relates generally to a device for generating an electromagnetic field correlated with the electromagnetic field of the heart of an organism, in particular a human being, in order to improve the condition thereof or its well-being, by its exposure to different types of electromagnetic stimulation. It also relates to a method of using the device, as well as the development of a user interface and an application computer program product.
- references in brackets ([]) refer to the list of references at the end of the text.
- ElectroCardioGram ECG
- MCG MagnetoCardioGram
- a source of electromagnetic activity whose waves propagate through the body, conveyed by meridian networks (vascular, nervous, etc.). This property is currently the most often taken up and / or used for diagnostic purposes (ECG, GCM), but not used or used for therapeutic purposes.
- the physical parameters of cardiac emissions such as the frequency range, for example, are not yet precisely known, but are able to be extrapolated on the basis of ECG parameters.
- acupuncture use the physiological pathways through which these rays propagate through the body (probably involving the meridian network) following blood flow patterns under cardiac impulse.
- Phototherapy or dynamic photo therapy, known by the acronym TPD
- TPD dynamic photo therapy
- US Patent No. 2008/0262394 entitled “Apparatus and methods for phototherapy” (Brian Pryor, Sean Xiaolu Wang) discloses a phototherapy apparatus in which therapeutic light is delivered through or near massage components. which provide a mechanical massage able to modify the properties of the tissue of the subject in thickness, density, etc. this in order to facilitate the absorption of the therapeutic light.
- document WO 2012/048302 describes a device for generating an electromagnetic wave synchronized with a signal of the human body. Specifically, it describes a device having a heartbeat sensor and generating an electromagnetic wave at the height of a meridian, palms of the hand or soles of the foot. This wave has an energy between 10uT and 500uT, is preferably pulsed.
- a device for generating an electromagnetic field correlated to the electromagnetic field of the heart of a living animal organism comprises: Real-time acquisition means of a signal representative of the electromagnetic activity of the heart in the form of electrocardiogram and / or electromagnetogram signals;
- Signal processing means for determining electromagnetic data to be generated according to the acquired signal and according to predefined information
- Means for generating an electromagnetic field according to the determined electromagnetic data are determined by the processing means such that the generated electromagnetic field strengthens the electromagnetic field of the heart in at least a portion of the living animal body when the generating means is disposed on or near the the skin of the said organism.
- the device tends to capture, analyze, regulate, reproduce and multiply the electromagnetic field of the heart, then restore / reintroduce minimally invasive or non-invasive synchronized coordination with the heart to amplify the electromagnetic field within the entire organization.
- the goal is to protect and restore the body's own electromagnetic field, which continuously undergoes electromagnetic waves from the environment, but also to magnify it to develop its beneficial properties for the body.
- the generation means are adapted to generate a right-turning spiral magnetic field
- the right-turning spiral magnetic field is generated by a permanent magnet of suitable shape;
- the means for generating the optical and magnetic components of the electromagnetic field are overmolded or mounted within a single modular protection box;
- light-emitting diodes are mechanically mounted on the underside of the modular protective housing, so that they can be placed in contact with the skin of the body, for the emission of the optical signal;
- It comprises a plurality of modular protection boxes
- the means for stimulating the magnetic field comprise a single electromagnet
- the means for stimulating the magnetic field comprise at least two electromagnets arranged so as to generate identical or inverted fields;
- the means for stimulating the magnetic field comprise three pairs of electromagnets so as to generate a magnetic field that can be controlled along the three axes of the space; and or
- It comprises software means for calculating in real time the response of the effect of the electromagnetic field gradients according to the three directions applied to the acquired signal.
- a navigation user software interface is the user interface of the above device and includes at least one of the following display features included in the group ⁇ real-time tracking the patient's cardiac activity with direct visualization of the stimulus signal trains and the evolution of the heartbeat; observation of the patient history followed and comparison; patient data management with choice of signal stimulus types to be imposed, including a healthy patient base that can serve as a signal stimulus reference; choice of the heartbeat detection algorithm with option to manually select QRS complex thresholds ⁇ .
- a method of generating an electromagnetic field correlated to the electromagnetic field of the heart of a living animal organism comprises:
- the electromagnetic data is determined such that the generated electromagnetic field strengthens the electromagnetic field of the heart in at least a portion of the living animal organism when the generated field is disposed on or near said organism.
- Another aspect relates to a computer program, comprising instructions for implementing the steps of a method as defined above during execution of the program by a computing unit of said apparatus.
- a method of treating a living animal organism using a device as above comprises:
- FIG. 1A represents a device for generating an electromagnetic wave according to one embodiment of the invention
- FIG. 1B shows the generation device of FIG. 1B in a particular physical configuration
- FIGS. 2a and 2b illustrate two alternative embodiments of acquisition means architectures
- FIGS. 3 and 4 represent screen prints of chronograms illustrating the execution times related to the functions of acquiring an ECG signal and of transmitting an optical signal by the device of FIG. 1;
- FIG. 7 represents an embodiment of a user interface of the device according to FIG. 1.
- a physiological finding is that the heart generates the most powerful and most extensive rhythmic electromagnetic field in the body. For example, in comparison with the electromagnetic field produced by the brain, the intensity of the cardiac electric field is a few tens of times greater in amplitude and penetrates all the cells of the body.
- the magnetic component created by Cardiac contractions are also significantly superior to the magnetic field of the brain and can be detected away from the body by magnetometers.
- the ubiquitous rhythmic field of the heart thus has a powerful influence on all the processes of the organism.
- brain rhythms are naturally synchronized with the rhythmic activity of the heart, and reflect, for example, changes / changes in heart rate, blood pressure, and respiration.
- the electromagnetic field of the heart produces an overall signal synchronized with various physiological processes of the body. It is spread in the body by one or more types of networks, probably the vascular network, nervous, etc.
- the heart communicates an electromagnetic field through a potentially additional interconnected network.
- the core generates continuous series of electromagnetic pulses, when the time interval between each beat varies dynamically and complex.
- the cells of the heart - especially those located in the apex of the heart - are unique cells in the organism, because in addition to the conductive properties, allowing to propagate the impulse of the heart contractions throughout the heart muscles, these cells have the ability to secrete active substances (in little like the glands). Moreover, the morphological shape of these cells is such that it generates an electromagnetic field in a spiral with the rotation to the right.
- the global electromagnetic field of the heart consists in the communion of 2 fields: the active electromagnetic field, produced in the atrium node - the pacemaker of the contractile activity of the heart - and the passive electromagnetic field ("silent"), created by the spiral-shaped heart cells, with the right rotation.
- heart tumors are either peripheral (aortic), very rare and most often benign (myxomas) and easy to remove.
- the objective is therefore to apply electric and magnetic fields of similar levels to those recorded by the electrocardiogram, on the external areas of the body used according to acupuncture techniques.
- the signal doses used are low so as not to have a direct offensive effect on the areas of application. Thus the doses are below the limits of the standards used in electrotherapy or exposure to infrared radiation.
- the use of acupuncture points as areas of application of electromagnetic fields must significantly enhance the role of these radiations.
- the purpose is to strengthen the electromagnetic field of the patient's heart (through the amplification and restoration of the electromagnetic field of the heart) by the phenomenon of resonance and thus improve the cardiac function. By improving cardiac function, many beneficial effects should be observed both psychically and physically.
- the general functioning of the immune system should be improved, therefore, among other things, the defenses against tumor proliferation.
- the device has a scope on the entire body through a global action on all organs. This effect is the result of a spread of stimulations step by step in the interconnected network of the nervous system. A "normative" nervous function is thus restored to the pathological patients, like that present in healthy subjects. This normative operation includes by its consequences an oxygenation correct organs, reactivation of defense mechanisms and restitution of physiological functions.
- the computation of the properties of the reinjected signals is based on a perfect or offset synchronization with the characteristics of the heart and the physiological rhythms of the body.
- the type of stimulation depends on the pathology or effect sought. This type of action can also be defined by the term "resonance”.
- Biophysical resonance is a new principle evidenced by the device described in this patent application. Like the “oscillation" resonance properties of physical objects (atoms, buildings, bridges ...), the proposed device allows for the first time its use in the human (or animal) setting. This biophysical resonance, in the case of certain pathologies, thus allows interaction with physiological rhythms by triggering mechanisms of regulation and stabilization of biological functions. The proposed device thus acts directly with the organs, their functioning and their interaction with the nervous system.
- the invention relates firstly to a device 1 said "cardio-synchronizer" for its function of synchronizing the heart rate of a human patient 2 to that of a healthy patient.
- Figure 1A shows the "cardio-synchronizer" in a mainly functional form while Figure 1B shows a representation in a preferred physical configuration in several housings.
- the device 1 comprises a processing module 3 including software means for in particular the processing of the information collected by the device 1 and signals to be transmitted to the patient.
- These software means include the visualization and recording of the ECG, the signal processing in real time, the retransmission of an average ECG signal and the constant updating of re-issued data to ensure good synchronization with the heartbeat.
- module 3 The description of module 3 will first be carried out, the software means being described at a later date.
- the processing module 3 notably provides the acquisition of the signals of an electrocardiograph (ECG) giving indications on the phases of the cardiac cycle.
- ECG electrocardiograph
- the device 1 comprises means for real-time acquisition of a signal representative of the electromagnetic activity of the heart in the form of electrocardiogram or electromagnetogram signals.
- sensors or electrodes 4 for collecting an ECG electrophysiological signal from an electromagnetic field of the patient 2.
- the integration of the electrocardiograph within the device 1 makes it possible to have a compact device capable of transmitting in real time electric and magnetic fields amplified in synchronization with the cardiac beats of the patient in cardiac rehabilitation or resuscitation rooms.
- the electrocardiograph 5 is not necessarily integrated with the device 1 and alternatively the electrocardiograph can simply be interoperated with the device 1 to provide the ECG signal or integrate the device 1.
- the ECG measurement signals collected by the electrocardiograph are then transmitted to the acquisition and processing module 3.
- the transmission of the ECG signal is performed according to a transmission mode selected from the group formed by the optical fiber transmission, radiofrequency (RF) transmission or transmission by shielded or unshielded electrical conductors.
- the processing module comprises a signal amplifier and a filter (not shown) providing preprocessing by filtering the acquisition channel, in order to reduce the recorded noise and to increase the quality of the acquired signal, with the gain, the dynamics and the bandwidth desired.
- the result is a pre-processed ECG signal to determine PQRS complexes of the cardiac signal.
- the processing module 3 comprises a microcontroller 31 1 which receives the ECG signal from the sensors / electrodes 4 via the electrocardiograph, samples this signal, applies to it a 50Hz digital filtering or 60Hz, and transmits the filtered signal, via an RS232 connection, to a computer 6 provided with a user interface 61 for viewing the ECG signal.
- an architecture with two microcontrollers can be provided that avoids a single microcontroller to bear the load associated with an incremental addition of functionalities that could lead to delays and deadlocks. in the treatments.
- a main microcontroller 312 performs the functions of receiving the ECG signal, of its digital sampling and of transmission of the filtered signal to the computer 6.
- an auxiliary microcontroller 313 contains a database of profiles corresponding to electrical / magnetic / optical stimulations. This auxiliary microcontroller 313 is in charge of transmitting the stimulation trains according to the selected profiles to respective magnetic stimulation 101, optical 102, electrical 103 modules, while the main microcontroller 312 initiates the execution of these stimulations.
- the importance of adding this auxiliary processor in the architecture of the processing module is the result of the findings described below.
- the chronograms described below illustrate the execution times related to the functions of acquisition of the ECG signal and emission of the optical signal by the device 1.
- ECG signal sampling requires 32 s for circuit stabilization before conversion by the main microcontroller, as shown in Figure 3.
- the ECG signal processing means 3 and the computer 6 make it possible to determine which electromagnetic signal must be generated and thus drive means for generating an electromagnetic field described below.
- the goal is then to reproduce as closely as possible the electromagnetic field of the heart with the lowest possible latency.
- the magnetic and optical waves of the stimulation are then identical in shape to those of the EEG signal (their amplitude exactly copies the heart waves of the patient with a possibility of stimulating a predefined wave of a reference EEG signal).
- the electrical stimulation by electrodes 8 is supplied independently of the main power supply, the power supply of the electrodes 8 being made by two batteries. This precaution, supported by an optical decoupling of the control signals, isolates the patient from the main electrical sector.
- the intensity of the electrical stimulation is variable and can be manually configured by an operator or doctor 1 1 depending on the discomfort felt by the patient. It should be noted that predefined acupuncture points are used as points of attachment of the external electrodes.
- the device 1 further comprises an outer removable protective housing 9 incorporating electromagnets 91 and LEDs (light-emitting diodes) 92, connected to the respective magnetic stimulation modules 101, optics 102.
- the electromagnets 91 and the LEDs 92 are overmolded or mounted within the same modular protective housing, the Inventor having discovered by experiments, and unexpectedly, that the modular organization within the same housing renders more conclusive results on the patient than when the electromagnets 91 were deported in a separate housing LED 92. Moreover this optimally reduces the apparent surface occupied by electromagnets 91 and LEDs 92.
- the number of magnetic coils can be freely increased as needed. Depending on the results, the intensity of the magnetic field produced can thus be modified. It is necessary that have at least two coils whose arrangement is detailed below. Alternatively, it is also possible to use three pairs of coils for generating magnetic field gradients according to the three spatial dimensions. Alternatively, a single coil can be used.
- the type of field can be changed: dispersive or concentrated field according to the disposition of the polarities of the electromagnets. "Concentrated" field stimulation is potentially the most efficient given the coherence of the induced polarization.
- the electromagnetic field generated by the core comprises a passive spiral component oriented to the right.
- the transmitter includes a second source of electromagnetic field called "static" - related to the shape of the transmitter (spiral with rotation to the right).
- This development aims to better reproduce the electromagnetic emissions of the heart, formed on the one hand by active (leading to the myocardial work) and passive (so-called “silent") emissions - created just thanks to the very particular shape of the cells of the heart.
- myocardium in the shape of a spiral, turned to the right). Fields are created by a component producing variable electrical potentials
- the power supply has been configured to provide stability of the ECG signal to other potentially disturbing currents and to allow increased consumption of the electromagnets.
- two certified power supplies for medical use are used: a power supply is dedicated to magnetic stimulation.
- a second power supply is dedicated to digital circuits. This decoupling makes it possible to improve the stability of the ECG signal by being independent of the current calls of the magnetic circuit. This configuration requires electronic schematics with separate blocks powered separately.
- the device 1 comprises light-emitting diodes or LEDs 92 mechanically mounted on the underside of the protective housing 9, intended to be placed in contact with the skin.
- the system conveyed infrared optical signals on optical fibers, and considerable signal losses were found.
- the LEDs have been connected to the housing 9 by short conductors, see on the underside of the housing 9. With this mode, the effect on the optical power is greatly increased.
- This optical stimulation is for example provided by 4 red LEDs and 2 infrared LEDs centered on 880 nm and powered by 12-bit intensity steps and 4.5 is stabilization.
- the device may comprise a plurality of housings 9.
- the housing 9 is positioned on the chest near the heart area to allow a good interaction between the heart and the electromagnetic waves generated by the housing.
- the housing 3 may also be connected to two or more electrodes for complementary electrical skin stimulation. Typically, it will be powered by the housing 3 to be able to deliver an electrical stimulation less than 10 ⁇ under 3V in steps of intensity on 12 bits and 4.5 s of stabilization.
- the device is intended to interact with the human body, it must comply with the security and certification rules in force as known to those skilled in the art.
- the electrical insulation must be particularly careful to avoid any risk of electrocution. Therefore, the general scheme described here must be adapted to include its rules to obtain a device that can be used in a medical context.
- the used software loaded in the device 1 implements the method of improving the condition of the human patient by strengthening the electromagnetic field within his body, comprising the following steps:
- the treatment step begins by determining an electrical baseline of rest during which no cardiac signal is observed as defined by the PQRS complex.
- the break with this baseline is caused by the appearance of the 'R' cardiac sequence and causes a "starting condition".
- the algorithms of stimulation initialize and can act in different ways depending on the imposed configuration.
- pacing starts when 50% of peak 'R' is reached by ECG (configurable). Following this first occurrence, the stimulation proceeds without additional delay if it is not a continuous updating of the minimum and maximum values of the ECG signal. These extremes set the minimum and maximum intensity of the 3 types of stimulation.
- the device reproduces the electrical characteristics recorded from the device. occurrence of a first peak 'R'.
- the system can either ignore the appearance of complex PQRS and initiate stimulation unconditionally, or update the trigger characteristics of stimulation (delay between two conditions of departure). This update occurs, for example, if the heart rate accelerates by reducing the delay between 2 'R' reference peaks.
- the stimulation cycles reproduce the change in the polarity of the myocardial tissue (direction of the B vector of the cardiac cells having a whole dipolar property). These external disturbances are constrained by the baseline which imposes a stimulation of zero intensity during its appearance.
- the electromagnetic intensities injected (or their inversion) causes a local modification of the cellular properties.
- Stimulus intensities are constrained by standards. Their minimum and maximum are recalculated every 7 seconds to reflect a possible change in cardiac characteristics. In any case, the detection of the baseline sets the intensity at zero, during which time the heart muscle is at rest.
- This software can be incorporated into the electronic circuits themselves, thus avoiding direct interaction with the user of the system.
- the predefined patient information is stored in module 3 which stores calibrated profiles of patients capable of providing the patient's normal heart rate for a given situation. In the absence of predefined information relating to the patient from the module 31, the predefined information uses a calibrated mode by default capable of providing a predefined average heart rate (at 60 beats per minute, for example).
- an algorithm base 12 makes it possible to feed the decision-making according to an algorithm defined by the operator.
- the user interface 61 of the computer 6 of the device 1 has the following information, as illustrated in FIG. 7:
- a history of the heart rate (a value per 10 seconds) to observe trends and their variation over time, in particular to monitor the effectiveness of treatment;
- the software is embedded in a nomadic device. It can notably be proposed as application software for a nomadic device of the Android TM or iPhone TM type, in particular with a view to a sports application for monitoring / strengthening the endurance capabilities of the cardiovascular system during the physical exertion of a person.
- the module 3 is embedded in the mobile device, the screen thereof as a user interface 61, and the mobile device is provided with adequate connections for connection with the box 9 of magnetic stimulation / optical and with electrodes or acupuncture needles 8.
- the method implemented by the software comprises a feedback loop enslaved to the normal electrical activity of the patient, so as to correct in real time the artifacts of the magnetic field and the optical / electrical signals produced.
- the method implemented by the software comprises a feedback loop introduced only for learning the effect of the electromagnetic field gradients applied on the acquired ECG signal, in order to correct in real time the artifacts of the field generated during the training sequence.
- appropriate magnetic field sensors may be used in the vicinity of the magnetic stimulation box to measure the magnitude of the local magnetic field vector or , alternatively, at least one pair of sensors for measuring the value of at least one magnetic field gradient in one direction.
- the application of the magnetic field and / or the attachment points of external electrodes and / or acupuncture needles for the application of electrical and / or optical signals to the patient can be performed on or around predefined acupuncture points.
- the device To use the device on a patient, it will preferably be lying on a medical examination bed and immobile so as not to distort the ECG signal during the treatment session.
- the duration of treatment depends on the therapy and can range from one minute to 1 hour.
- the present device has many applications such as, but not limited to:
- the device according to the invention has a certain advantage if it is integrated with the control device for cardiac functions (called “monitoring”) in the cardiac rehabilitation and resuscitation rooms, for use in the postoperative period or after an infarction, but also in rehabilitation centers.
- monitoring the control device for cardiac functions
- the training of the electromagnetic field of the heart can be applied to optimize the endurance capabilities of the heart during stress tests and in the preparation of top athletes.
- the intended effect of the simultaneous application of the device with the cardiac function control device is to strengthen the electromagnetic field of the patient's heart through the phenomenon of physical resonance and thus improve the operation of its system cardiovascular.
- the acquisition part can be limited to a simple interface with a commercial electrocardiograph for recovering cardiac signals.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1356198 | 2013-06-27 | ||
FR1356198A FR3007632B1 (fr) | 2013-06-27 | 2013-06-27 | Procede et dispositif d'amelioration de la condition d'un patient humain par l'interaction avec un champ electromagnetique au sein de son organisme |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014207407A1 true WO2014207407A1 (fr) | 2014-12-31 |
Family
ID=49667271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2014/051648 WO2014207407A1 (fr) | 2013-06-27 | 2014-06-27 | Dispositif de génération d'un champ électromagnétique corrélé au champ électromagnétique du coeur d'un organisme et procédé associé |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3007632B1 (fr) |
WO (1) | WO2014207407A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105595988A (zh) * | 2015-12-23 | 2016-05-25 | 石家庄翰纬医疗设备有限公司 | 心电波形的绘制方法和计算设备 |
CN111918694A (zh) * | 2018-02-01 | 2020-11-10 | 心脏起搏器股份公司 | 针对mri环境设计的可插入心脏监视设备 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2820327A1 (fr) * | 2001-02-06 | 2002-08-09 | Mohamed Ayari | Procede pour l'obtention d'un ensemble de champs electromagnetiques a visees diagnostiques, preventives, therapeutiques et biotechnologiques |
WO2010078581A1 (fr) * | 2009-01-05 | 2010-07-08 | Plextronics, Inc. | Système d'éclairage pour photothérapie à diodes électroluminescentes organiques |
WO2012048302A2 (fr) * | 2010-10-07 | 2012-04-12 | Biomobie Corp. | Terminal d'excitation portatif et émetteur emf permettant l'optimisation dynamique de l'émission et de l'effet thérapeutique et système thérapeutique à distance |
US20120265048A1 (en) * | 2011-04-15 | 2012-10-18 | Avazzia, Inc. | System for providing magnetic, light and crystal energy therapy |
-
2013
- 2013-06-27 FR FR1356198A patent/FR3007632B1/fr active Active
-
2014
- 2014-06-27 WO PCT/FR2014/051648 patent/WO2014207407A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2820327A1 (fr) * | 2001-02-06 | 2002-08-09 | Mohamed Ayari | Procede pour l'obtention d'un ensemble de champs electromagnetiques a visees diagnostiques, preventives, therapeutiques et biotechnologiques |
WO2010078581A1 (fr) * | 2009-01-05 | 2010-07-08 | Plextronics, Inc. | Système d'éclairage pour photothérapie à diodes électroluminescentes organiques |
WO2012048302A2 (fr) * | 2010-10-07 | 2012-04-12 | Biomobie Corp. | Terminal d'excitation portatif et émetteur emf permettant l'optimisation dynamique de l'émission et de l'effet thérapeutique et système thérapeutique à distance |
US20120265048A1 (en) * | 2011-04-15 | 2012-10-18 | Avazzia, Inc. | System for providing magnetic, light and crystal energy therapy |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105595988A (zh) * | 2015-12-23 | 2016-05-25 | 石家庄翰纬医疗设备有限公司 | 心电波形的绘制方法和计算设备 |
CN111918694A (zh) * | 2018-02-01 | 2020-11-10 | 心脏起搏器股份公司 | 针对mri环境设计的可插入心脏监视设备 |
Also Published As
Publication number | Publication date |
---|---|
FR3007632A1 (fr) | 2015-01-02 |
FR3007632B1 (fr) | 2021-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11253701B2 (en) | Transcranial stimulation device and method based on electrophysiological testing | |
Hamaoka et al. | The use of muscle near-infrared spectroscopy in sport, health and medical sciences: recent developments | |
Castermans et al. | About the cortical origin of the low-delta and high-gamma rhythms observed in EEG signals during treadmill walking | |
Bronzino | Medical devices and systems | |
Edwards et al. | Sensory detection thresholds are modulated across the cardiac cycle: Evidence that cutaneous sensibility is greatest for systolic stimulation | |
US8951203B2 (en) | Measures of cardiac contractility variability during ischemia | |
US9457190B2 (en) | Coordinating musculoskeletal and cardiovascular hemodynamics | |
Shahriari et al. | Emerging frontier of peripheral nerve and organ interfaces | |
JP2014522713A (ja) | 頚部インピーダンスを使用する生理学的パラメータの判定 | |
CN107529988A (zh) | 心房颤动检测 | |
US20210353957A1 (en) | Method and apparatus for wearable device with eeg and biometric sensors | |
CN101642369A (zh) | 自主神经功能生物反馈方法和系统 | |
Weng | Electromagnetic activation of the calf muscle pump | |
Barutcu et al. | Do mobile phones pose a potential risk to autonomic modulation of the heart? | |
AU2015336127B2 (en) | System and methods for non-invasively monitoring autonomic nerve activity | |
US20140051945A1 (en) | Expanded frequency electroencephalography/electrocardiography light apparatus and method of use | |
US20210307684A1 (en) | System and method for implementing a stimulation protocol | |
WO2014207407A1 (fr) | Dispositif de génération d'un champ électromagnétique corrélé au champ électromagnétique du coeur d'un organisme et procédé associé | |
Gospodinov et al. | Three-sensor portable information system for physiological data registration | |
Petrėnas et al. | Lead systems and recording devices | |
CA2981402A1 (fr) | Procede et systeme d'identification d'un isthme dans une cartographie tridimensionnelle | |
Hasnan et al. | Muscle oxygenation during hybrid arm and functional electrical stimulation–evoked leg cycling after spinal cord injury | |
Chevalier et al. | Effects of grounding (Earthing) on massage therapists: an exploratory study | |
Yol et al. | Design of real time cardiac arrhythmia detection device | |
Castells et al. | Data and signals for the assessment of the cardiovascular system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14745185 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WPC | Withdrawal of priority claims after completion of the technical preparations for international publication |
Ref document number: 1356198 Country of ref document: FR Date of ref document: 20151211 Free format text: WITHDRAWN AFTER TECHNICAL PREPARATION FINISHED |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: CONSTATION DE LA PERTE D'UN DROIT CONFORMEMENT A LA REGLE 112(1) CBE, (OEB FORM 1205A EN DATE DU 24.03.2017) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14745185 Country of ref document: EP Kind code of ref document: A1 |